Search

You searched for "cancer"

853 results found

RSM (Royal Society of Medicine) Complexity and Complications: Navigating Advanced Prostate Cancer

21 November 2025
This year’s RSM Cancer Day will focus on the evolving management of prostate cancer. With emerging evidence supporting radical prostatectomy in oligometastatic disease, the programme will examine patient selection, treatment strategies, and the latest advances for managing advanced-stage cases.

EAU (European Association of Urology) Masterclass on Focal therapy for localised prostate cancer

5 December 2024 -6 December 2024
Focal Therapy (FT) is a promising treatment option aimed at improving the management of localised prostate cancer. This masterclass will provide you with an extensive review of the rationale for FT, the patient selection modalities and the available energy sources (HIFU, Cryo, IRE, Laser, Brachytherapy). Gain further knowledge and better understand the FT benefits.

Prostate Cancer UK: Specialist Education Conference 2025 (Free)

26 March 2025 -27 March 2025
You’ll hear from a panel of expert speakers who’ll share their knowledge and best practice guidance about prostate cancer care. They’ll provide the latest information and guidance, helping you to provide best practice care for your patients. You’ll also cover CPD requirements by attending. From 9am - 12 noon.

APCCC (Advanced Prostate Cancer Consensus Conference) Diagnostics 2025

27 February 2025 -28 February 2025
The diagnostic abilities for assessing prostate cancer patients have significantly evolved in the last years. Ranging from advanced imaging modalities for detection, new innovative liquid and tissue based biomarkers as well as the recent introduction of PSMA PET imaging have...

Prostate Cancer UK: Towards Equity: Exploring Prostate Cancer Disparities Experienced by Black Men - data and evidence mini conference (Free)

13 March 2025
We will delve into why Prostate Cancer UK is exploring health inequalities, starting with Black men and highlight valuable research findings and challenges in health inequalities space, with keynote speaker Dr Tom Cowling, who will share his insights from the latest England and Wales NPCA State of the Nation Report, including sociodemographic and tumour data from England. From 1.30 pm - 4.30pm

Prostate Cancer UK announced as official charity partner for MOBO Awards

6 February 2025 | Awards, Conferences & Anniversaries
The stage is set! Global dancehall queen Spice, UK rap kings Krept and Konan and the multi-talented Bashy are the first wave of performers announced to ignite the stage at the 2025 MOBO Awards.

PROSPACKS supports prostate cancer patients starting treatment in Scotland

22 April 2025
Men across Scotland undergoing treatment for prostate cancer can benefit from new care and support packs thanks to a project by charity Prostate Scotland and long-term funder, the Grand Lodge of Scotland. PROSPACKS – tailored packs for men beginning radiotherapy,...

Announcing a new specialist distributor of medical devices for prostate cancer

10 January 2022 | Contracts & Distributors, Research & Development
Healthcare Supply Solutions are a new distributor focussed on medical devices for the diagnosis and management of Prostate Cancer.

New ultrasound imaging technique reliably spots prostate cancer, initial patient trial reveals

16 January 2025
A groundbreaking new imaging approach developed by researchers at Heriot-Watt University has shown ‘extremely encouraging’ results in early-stage clinical trials on prostate cancer at the Western General Hospital in Edinburgh, Scotland. The ongoing clinical trial demonstrated an initial 94% sensitivity...

NHS Greater Glasgow and Clyde Prostate Cancer Nurse Specialist wins Continence and Urology Nurse of the Year at BJN Awards 2025

8 April 2025
Leann McLaughlin, a Uro-Oncology CNS who specialises in prostate cancer at Inverclyde Royal Hospital, NHS Greater Glasgow and Clyde, has won Urology and Continence Nurse of the Year at the British Journal of Nursing (BJN) Awards 2025. The prestigious event...

Prostate Cancer UK warns of over 8,600 ‘missing men’ as referrals drop by 52,000

5 May 2021 | Research & Development, COVID-19
The Covid-19 pandemic has led to around 52,000 (28%) fewer urgent prostate cancer referrals in England alone, according to statistics shared by Prostate Cancer UK. It’s estimated that more than 8,600 fewer men started treatment for...

Dogs and humans share a bladder cancer biomarker: a new discovery that opens doors for early detection and treatment

9 September 2025
A new scientific study has identified a new molecular biomarker that could help doctors detect aggressive early-stage bladder cancer, such as high-grade non-muscle invasive bladder cancer (NMIBC), in both dogs and humans. This discovery advances our knowledge of how aggressive...